Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011 (2011), Article ID 792070, 8 pages
http://dx.doi.org/10.4061/2011/792070
Research Article

ApoE4-Driven Accumulation of Intraneuronal Oligomerized Aβ42 following Activation of the Amyloid Cascade In Vivo Is Mediated by a Gain of Function

1Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
2George P. and Cynthia Woods Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX 77555-0857, USA
3Departments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA 92093-0624, USA

Received 4 October 2010; Revised 21 November 2010; Accepted 3 December 2010

Academic Editor: Katsuhiko Yanagisawa

Copyright © 2011 Lia Zepa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kim, J. M. Basak, and D. M. Holtzman, “The role of apolipoprotein E in Alzheimer's disease,” Neuron, vol. 63, no. 3, pp. 287–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. W. Mahley and S. C. Rall, “Apolipoprotein E: far more than a lipid transport protein,” Annual Review of Genomics and Human Genetics, vol. 1, no. 2000, pp. 507–537, 2000. View at Google Scholar · View at Scopus
  3. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al., “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science, vol. 261, no. 5123, pp. 921–923, 1993. View at Google Scholar · View at Scopus
  4. W. J. Strittmatter, K. H. Weisgraber, D. Y. Huang et al., “Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 8098–8102, 1993. View at Google Scholar · View at Scopus
  5. L. Bertram, M. B. McQueen, K. Mullin, D. Blacker, and R. E. Tanzi, “Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database,” Nature Genetics, vol. 39, no. 1, pp. 17–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. T. Hyman, T. Gomez-Isla, G. W. Rebeck et al., “Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 802, pp. 1–5, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. D. E. Schmechel, A. M. Saunders, W. J. Strittmatter et al., “Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 20, pp. 9649–9653, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Dolev and D. M. Michaelson, “A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 38, pp. 13909–13914, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. Holtzman, “In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology,” Journal of Molecular Neuroscience, vol. 23, no. 3, pp. 247–254, 2004. View at Google Scholar · View at Scopus
  10. J. Jordán, M. F. Galindo, R. J. Miller, C. A. Reardon, G. S. Getz, and M. J. LaDu, “Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures,” Journal of Neuroscience, vol. 18, no. 1, pp. 195–204, 1998. View at Google Scholar · View at Scopus
  11. M. J. LaDu, M. T. Falduto, A. M. Manelli, C. A. Reardon, G. S. Getz, and D. E. Frail, “Isoform-specific binding of apolipoprotein E to β-amyloid,” Journal of Biological Chemistry, vol. 269, no. 38, pp. 23403–23406, 1994. View at Google Scholar · View at Scopus
  12. P. S. Puttfarcken, A. M. Manelli, M. T. Falduto, G. S. Getz, and M. J. LaDu, “Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures,” Journal of Neurochemistry, vol. 68, no. 2, pp. 760–769, 1997. View at Google Scholar · View at Scopus
  13. H. Belinson, D. Lev, E. Masliah, and D. M. Michaelson, “Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits,” Journal of Neuroscience, vol. 28, no. 18, pp. 4690–4701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. van Meer, S. Acevedo, and J. Raber, “Impairments in spatial memory retention of GFAP-apoE4 female mice,” Behavioural Brain Research, vol. 176, no. 2, pp. 372–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Arendt, C. Schindler, M. K. Brückner et al., “Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele,” Journal of Neuroscience, vol. 17, no. 2, pp. 516–529, 1997. View at Google Scholar · View at Scopus
  16. B. Teter, “ApoE-dependent plasticity in Alzheimer's disease,” Journal of Molecular Neuroscience, vol. 23, no. 3, pp. 167–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. F. White, J. A. R. Nicoll, A. D. Roses, and K. Horsburgh, “Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion,” Neurobiology of Disease, vol. 8, no. 4, pp. 611–625, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Egensperger, S. Kösel, U. von Eitzen, and M. B. Graeber, “Microglial activation in Alzheimer disease: association with APOE genotype,” Brain Pathology, vol. 8, no. 3, pp. 439–447, 1998. View at Google Scholar · View at Scopus
  19. H. Belinson, Z. Kariv-Inbal, R. Kayed, E. Masliah, and D. M. Michaelson, “Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloidβ resulting in neurodegeneration,” Journal of Alzheimer's Disease, vol. 22, no. 3, pp. 959–970, 2010. View at Google Scholar
  20. P. M. Sullivan, H. Mezdour, Y. Aratani et al., “Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis,” Journal of Biological Chemistry, vol. 272, no. 29, pp. 17972–17980, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Levi, A. L. Jongen-Relo, J. Feldon, A. D. Roses, and D. M. Michaelson, “ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory,” Neurobiology of Disease, vol. 13, no. 3, pp. 273–282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Kayed and C. G. Glabe, “Conformation-Dependent Anti-Amyloid Oligomer Antibodies,” Methods in Enzymology, vol. 413, pp. 326–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Kayed, E. Head, J. L. Thompson et al., “Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis,” Science, vol. 300, no. 5618, pp. 486–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. U. Beffert, N. Aumont, D. Dea, S. Lussier-Cacan, J. Davignon, and J. Poirier, “β-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons,” Journal of Neurochemistry, vol. 70, no. 4, pp. 1458–1466, 1998. View at Google Scholar · View at Scopus
  25. U. Beffert, N. Aumont, D. Dea, S. Lussier-Cacan, J. Davignon, and J. Poirier, “Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures,” Molecular Brain Research, vol. 68, no. 1-2, pp. 181–185, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Yamauchi, M. Tozuka, H. Hidaka, T. Nakabayashi, M. Sugano, and T. Katsuyama, “Isoform-specific effect of apolipoprotein E on endocytosis of β-amyloid in cultures of neuroblastoma cells,” Annals of Clinical and Laboratory Science, vol. 32, no. 1, pp. 65–74, 2002. View at Google Scholar · View at Scopus
  27. M. J. Sharman, M. Morici, E. Hone et al., “APOE genotype results in differential effects on the peripheral clearance of amyloid-β42 in APOE knock-in and knock-out mice,” Journal of Alzheimer's Disease, vol. 21, no. 2, pp. 403–409, 2010. View at Publisher · View at Google Scholar
  28. R. Deane, A. Sagare, K. Hamm et al., “ApoE isoform-specific disruption of amyloid β peptide clearance from mouse brain,” Journal of Clinical Investigation, vol. 118, no. 12, pp. 4002–4013, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. H. Petersen, N. Alikhani, H. Behbahani et al., “The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13145–13150, 2008. View at Publisher · View at Google Scholar